At Maudsley Learning, we have worked extensively with pharmaceutical companies to provide mental health-related education for research and commercial teams, and healthcare professionals working across mental and physical health conditions. We have the expertise to help pharmaceutical organisations develop core skills and knowledge of mental health-related topics for educational, research and whole team wellbeing / development purposes.

We focus on experiential, interactive learning, providing learners with the highest quality training experience possible, whether in-person or online. We work with a wide range of experts in mental healthcare and neuroscience and can offer custom-made programs to meet the education and training needs of your organisation. We would welcome the opportunity to explore this further and discuss how else we can support you and your clients.

Ways to support your organisation

Recent projects we have delivered in partnership with pharmaceutical companies

Understanding the patient journey in schizophrenia

This one-day course will give attendees a better understanding of the experience of someone with schizophrenia, throughout the patient journey.

Treatment-resistant mood disorders and psychosis

Treatment-resistant mood disorders and treatment-resistant psychosis. These one-day courses discuss the latest evidence for the assessment and management of treatment-resistant mood disorders and psychosis.

Improving mental healthcare of people with cancer

This two-day course is aimed at oncologists and oncology specialist nurses, providing them with essential skills and knowledge to assist patients struggling with their mental health and wellbeing.

Mental health firstaid skills for oncology support team

Mental health first aid skills for oncology support workers course focuses on mental health first aid skills for support workers in oncology, but can be easily adapted for those working in a range of environments.

New and emerging treatments in psychiatry

From psychedelics to gut microbiome, this two-day course will introduce clinicians to the major new interventions in psychiatry with strong or promising clinical evidence.